Total submissions: 25
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000074991 | SCV000108208 | likely benign | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Multifactorial likelihood analysis posterior probability 0.001-0.049 |
Gene |
RCV000202213 | SCV000170369 | benign | not specified | 2013-10-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Vantari Genetics | RCV000126840 | SCV000267053 | benign | Hereditary cancer-predisposing syndrome | 2015-12-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000202213 | SCV000302880 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Color Diagnostics, |
RCV000126840 | SCV000537388 | benign | Hereditary cancer-predisposing syndrome | 2015-04-06 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000126840 | SCV000679732 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-12 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000611257 | SCV000744286 | benign | Lynch syndrome 5 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000611257 | SCV001135785 | likely benign | Lynch syndrome 5 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000202213 | SCV001158616 | benign | not specified | 2019-01-25 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000611257 | SCV001300596 | likely benign | Lynch syndrome 5 | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Labcorp Genetics |
RCV002055074 | SCV002365515 | benign | Hereditary nonpolyposis colorectal neoplasms | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000202213 | SCV002552276 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001572716 | SCV002585788 | benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | MSH6: BS1, BS2 |
Ambry Genetics | RCV000126840 | SCV002636066 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003149728 | SCV003837637 | benign | Breast and/or ovarian cancer | 2021-06-22 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000611257 | SCV004015991 | likely benign | Lynch syndrome 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001572716 | SCV005256873 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000202213 | SCV000257300 | likely benign | not specified | no assertion criteria provided | clinical testing | ||
Department of Pathology and Laboratory Medicine, |
RCV001353859 | SCV000592568 | benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The c.457+13A>G variant has been previously reported in the literature in individuals with CRC (8/295 chromosomes) but the frequency in controls did not differ significantly from the cases tested (6/185 chromosomes) (Peterlongo_2003_14520694, Woods_2005_16203774). This variant was listed in dbSNP (rs1800933) 'with untested allele' and reported from the 1000 genomes 4 times (MAF of 0.002) The exome variant server reported this variant in a European cohort with the following frequency increasing the likelihood this variant does not have clinical significance: G=54/A=8546. Further, this variant does not occur within the splicing consensus sequence increasing the likelihood this variant does not have clinical significance. | |
Diagnostic Laboratory, |
RCV000611257 | SCV000734209 | likely benign | Lynch syndrome 5 | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000611257 | SCV000745647 | benign | Lynch syndrome 5 | 2016-10-07 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001572716 | SCV001797513 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000202213 | SCV001906026 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000202213 | SCV001922705 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000202213 | SCV001956698 | benign | not specified | no assertion criteria provided | clinical testing |